Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increasing incidence of lentigo maligna and lentigo maligna melanoma in Catalonia.
Matas-Nadal C, Malvehy J, Ferreres JR, Boada A, Bodet D, Segura S, Salleras M, Azon A, Bel-Pla S, Bigata X, Campoy A, Curcó N, Dalmau J, Formigon M, Gonzalez A, Just M, Llistosella E, Nogues ME, Pedragosa R, Pujol JA, Sabat M, Smandia JA, Zaballos P, Puig S, Martí RM. Matas-Nadal C, et al. Among authors: marti rm. Int J Dermatol. 2019 May;58(5):577-581. doi: 10.1111/ijd.14334. Epub 2018 Dec 13. Int J Dermatol. 2019. PMID: 30548854
Temozolomide as prophylaxis for melanoma brain metastases.
Conill C, González-Cao M, Jorcano S, Puig S, Malvehy J, Martí R, Castel T. Conill C, et al. Melanoma Res. 2004 Feb;14(1):73-4. doi: 10.1097/00008390-200402000-00012. Melanoma Res. 2004. PMID: 15091198 Clinical Trial. No abstract available.
Small cell melanoma and ulceration as predictors of positive sentinel lymph node in malignant melanoma patients.
Cuéllar FA, Vilalta A, Rull R, Vidal-Sicart S, Palou J, Ventura PJ, Pous E, Quinto L, Malvehy J, Martí R, Puig S, Vilella R, Soler J, Benítez D, Yachi E, Lecha M, Pons F, Conill C, Visa J, Castel T; Malignant Melanoma Group. Cuéllar FA, et al. Melanoma Res. 2004 Aug;14(4):277-82. doi: 10.1097/01.cmr.0000136712.82910.a1. Melanoma Res. 2004. PMID: 15305158
Role of the CDKN2A locus in patients with multiple primary melanomas.
Puig S, Malvehy J, Badenas C, Ruiz A, Jimenez D, Cuellar F, Azon A, Gonzàlez U, Castel T, Campoy A, Herrero J, Martí R, Brunet-Vidal J, Milà M. Puig S, et al. J Clin Oncol. 2005 May 1;23(13):3043-51. doi: 10.1200/JCO.2005.08.034. J Clin Oncol. 2005. PMID: 15860862
Seborrheic keratosislike melanoma with folliculotropism.
Carrera C, Segura S, Palou J, Puig S, Segura J, Martí RM, Malvehy J. Carrera C, et al. Among authors: marti rm. Arch Dermatol. 2007 Mar;143(3):373-6. doi: 10.1001/archderm.143.3.373. Arch Dermatol. 2007. PMID: 17372102
Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
Goldstein AM, Chaudru V, Ghiorzo P, Badenas C, Malvehy J, Pastorino L, Laud K, Hulley B, Avril MF, Puig-Butille JA, Miniere A, Marti R, Chompret A, Cuellar F, Kolm I, Mila M, Tucker MA, Demenais F, Bianchi-Scarra G, Puig S, de-Paillerets BB. Goldstein AM, et al. Int J Cancer. 2007 Aug 15;121(4):825-31. doi: 10.1002/ijc.22712. Int J Cancer. 2007. PMID: 17397031 Free article.
Prognostic value of tyrosinase reverse transcriptase PCR analysis in melanoma sentinel lymph nodes: long-term follow-up analysis.
González Cao M, Badenas C, Malvehy J, Martí R, Puig-Butille JA, Castel T, Rull R, Vilalta A, Vidal-Sicart S, Palou J, Vilella R, Conill C, Sánchez M, Walker G, Pons F, Puig S. González Cao M, et al. Clin Exp Dermatol. 2009 Dec;34(8):863-9. doi: 10.1111/j.1365-2230.2009.03210.x. Epub 2009 May 5. Clin Exp Dermatol. 2009. PMID: 19438551
106 results